Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy - Wikidata - thesis-toulmin - TriplyDB

Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy

Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy

http://www.wikidata.org/entity/Q30586812

about

Chemoresistance in human ovarian cancer: the role of apoptotic regulators Irradiation specifically sensitises solid tumour cell lines to TRAIL mediated apoptosis Imaging-based tumor treatment response evaluation: review of conventional, new, and emerging concepts Tumor progression locus 2 (Tpl2) kinase as a novel therapeutic target for cancer: double-sided effects of Tpl2 on cancer Imaging proteolytic activity in live cells and animal models Inflammatory cytokine regulation of TRAIL-mediated apoptosis in thyroid epithelial cells The antidiabetic drug ciglitazone induces high grade bladder cancer cells apoptosis through the up-regulation of TRAIL Identification of a new murine tumor necrosis factor receptor locus that contains two novel murine receptors for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)Radiation-induced tumor neoantigens: imaging and therapeutic implications.Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy.Early therapy assessment of combined anti-DR5 antibody and carboplatin in triple-negative breast cancer xenografts in mice using diffusion-weighted imaging and (1)H MR spectroscopy Pretreatment prediction of brain tumors' response to radiation therapy using high b-value diffusion-weighted MRI Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response.Diffusion MRI in early cancer therapeutic response assessment.The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome.Antitumor activity and prolonged expression from a TRAIL-expressing adenoviral vector.A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the bone Repression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progression.Diffusion magnetic resonance imaging: an imaging treatment response biomarker to chemoradiotherapy in a mouse model of squamous cell cancer of the head and neck Synergy between anti-CCL2 and docetaxel as determined by DW-MRI in a metastatic bone cancer model Intravital imaging of tumor apoptosis with FRET probes during tumor therapy.Acute toxicity of a single dose DATR, recombinant soluble human TRAIL mutant, in rodents and crab-eating macaques.2-Deoxy-D-glucose enhances TRAIL-induced apoptosis in human melanoma cells through XBP-1-mediated up-regulation of TRAIL-R2 Identification of novel molecular regulators of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in breast cancer cells by RNAi screening.Inhibition of ataxia telangiectasia mutated kinase activity enhances TRAIL-mediated apoptosis in human melanoma cells Modulation of TRAIL resistance in colon carcinoma cells: different contributions of DR4 and DR5.Induction of cell death in human immunodeficiency virus-infected macrophages and resting memory CD4 T cells by TRAIL/Apo2l Preligand assembly domain-mediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosis Early changes in apparent diffusion coefficient as an indicator of response to sorafenib in hepatocellular carcinoma.Predicting and monitoring cancer treatment response with diffusion-weighted MRI.CD40 ligand (CD154) and tumour necrosis factor-related apoptosis inducing ligand (Apo-2L) in haematological malignancies.TRAIL in cancer therapy: present and future challenges.Radiotherapy sensitization by tumor-specific TRAIL gene targeting improves survival of mice bearing human non-small cell lung cancer.Ionizing radiation as a response-enhancing agent for CD95-mediated apoptosis.Advances in Viral Vector-Based TRAIL Gene Therapy for Cancer.Insights into cancer therapeutic design based on p53 and TRAIL receptor signaling.Noninvasive real-time imaging of apoptosis.TRAIL/Apo-2L: mechanisms and clinical applications in cancer.Tumor-specific apoptotic gene targeting overcomes radiation resistance in esophageal adenocarcinoma MADD knock-down enhances doxorubicin and TRAIL induced apoptosis in breast cancer cells

P2860

Q24791433-85A5542D-0775-4C75-94FE-04F6A0066C10 Q24798681-DAE959B5-6D58-4C10-8221-F78D7230A4F4 Q26863654-0E23B331-767C-4B21-AE20-D03584038C9E Q27021391-97AA0E90-8095-40E0-A998-04D101080764 Q27314960-6FF9F0BD-A4EF-4432-8AEA-0D9806E6786D Q28203099-9BABF024-0207-4BD1-A8FE-93F5BB26CE99 Q28478349-1F922557-7AA6-4C02-9E6D-CA28D14DF0D2 Q28505264-911FAA25-65E7-468F-B8F3-90B5A991DB90 Q30473856-2A072D1B-3F1D-4889-B2AD-431436F9E17C Q30599587-C041B182-4FFF-4C6A-93C7-0E6CDB9CD81F Q30682911-D12EA19C-F548-46F4-9AEE-5CD23F5DF16D Q30930689-D67F0D02-69F7-4BCB-A699-08106B1681EB Q30986317-7C486CC8-5AED-46E8-A033-78988D7CB294 Q31037179-F523492E-AF79-4ACE-9834-3818D86DE8A9 Q31043513-9A5BB75C-64B8-40BD-A294-CE0183873405 Q31087174-65BBAD59-ECCB-46AE-A650-38BFC3DC28FB Q31140219-56747F00-C019-403A-B0C0-C03997857888 Q33288897-95FE190B-F534-4C17-8B51-9E86D93E2867 Q33388183-BC7BC80C-BB6A-4F9A-837D-302B1575BBD3 Q33414714-21709B83-B911-44B6-9588-FC469EC030D1 Q33471546-F326875D-3F86-4DED-B864-D4242921E86E Q33522351-79CBAE61-8C6E-4DBE-996E-9BA53305545F Q33578562-C9669020-0883-422A-9BDF-E5348EF2A3DC Q33739941-916BB53D-11CB-4EF2-B8FA-DCCB5B644D8F Q33803816-8D9D32F6-F70E-41EE-9A44-232432F16610 Q33805582-3D5C3F1E-3631-46C0-8F14-2147451299E6 Q33849293-4BFC7F9A-43FE-4043-A6AC-10AB21BB8722 Q33991741-EBD1E003-F61B-4B78-BA7A-A25A6E112AC9 Q34029449-EB0D952C-430A-44CA-B926-97797109DE04 Q34052992-0DD0066D-67A6-4FD5-86DD-BC6422ABD2C2 Q34266298-C715C4F5-7864-46C3-99E3-09ABD706A02D Q34291312-8AC37A15-C8A0-4C11-BF20-B785EE50C3D5 Q34313135-4D55540E-06FE-4CD0-84B2-355BF1D70197 Q34320209-3EC07563-B459-4735-A322-04E3D53834CD Q34384021-E62057B6-C4AA-437C-A82F-0587DE7FE36D Q34425447-08540FFF-E481-4582-8323-14449A715337 Q34429029-914814AB-9576-4B4B-A1D4-B3A9ABDC1697 Q34482821-7B7BDB2C-2598-4E00-8947-22930EE4346F Q34595455-A40AAA87-6C81-48BA-8112-D0253CC9912C Q34607094-6CCE46E3-48A8-49AC-A591-58924C57E12F

P2860

Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy

http://www.wikidata.org/entity/Q30586812

description

2000 nî lūn-bûn

@nan

2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Combined effect of tumor necro ...... ation in breast cancer therapy

@ast

Combined effect of tumor necro ...... ation in breast cancer therapy

@en

type

label

Combined effect of tumor necro ...... ation in breast cancer therapy

@ast

Combined effect of tumor necro ...... ation in breast cancer therapy

@en

prefLabel

Combined effect of tumor necro ...... ation in breast cancer therapy

@ast

Combined effect of tumor necro ...... ation in breast cancer therapy

@en

P1433

Q30586812-7EF5AB05-ACD4-4F06-AE5C-1E9DA9FAE5DC

P1476

Q30586812-BB24ADF5-0815-4DFF-8D5A-87781421B2AB

P2093

Q30586812-34977098-3939-4621-B748-CD0E132A023D

Q30586812-5BACFEE0-0C89-4DB2-BB77-13259D3BB57E

Q30586812-7CDC2ED7-7442-4843-801C-7C3091589510

Q30586812-9251094E-6015-467A-9A3E-A49F8696BBAD

Q30586812-A4AE53C6-3986-449A-A831-9DF5EB58C154

Q30586812-EC4A27A4-9591-4A22-BD06-B24C920D8A68

Q30586812-EF85D06D-AB99-4852-99D7-2883738FA21D

Q30586812-FBD1897D-6300-4846-993E-FFA58AA7B99A

P2860

Q30586812-00131B2E-D4CB-460A-86DA-D3B42F75DC56

Q30586812-02042476-2A81-420F-B3B7-1A9E09AF8DC8

Q30586812-07974888-8F0D-4970-B4C2-76C3D2E6552D

Q30586812-0ECB6C44-E1B2-4BB3-B7EC-4C127756A756

Q30586812-10EB7AEE-48D0-4869-BD01-979B42037D1C

Q30586812-22C5AFDE-F774-41F6-983D-D52537C87F42

Q30586812-236A5331-01FB-4736-818D-1DCF0442C2DF

Q30586812-25ADB37C-A8F4-4D11-BF83-53C9E95C0990

Q30586812-25CD7D12-F387-4A2F-ADC9-640B50D23B30

Q30586812-3252F277-CEAF-418D-BE1E-1976C20B77CC

P304

Q30586812-306A3303-6950-4856-959F-F1AC1ADC6EA1

P31

Q30586812-D2D97093-E187-4B03-BA38-00E6B2C489F2

P356

Q30586812-55301D5E-CAD5-4321-8129-5EAF0D1F4BE0

P407

Q30586812-AEE3D8BA-7AF8-43FB-B882-02518DFCA4DB

P433

Q30586812-3B6BAAE4-ED9B-43CB-9685-341720BFDC31

P478

Q30586812-59D81743-ACAC-4A39-A550-00D332515EAB

P577

Q30586812-B9C9EB62-84C2-415B-BAE8-7DF1627EEDEF

P5875

Q30586812-1DE673B7-0BC2-47D0-A44F-01C28A355ED7

P698

Q30586812-91D1E073-505B-418E-83CD-47C3B9A74930

P921

Q30586812-07C868CD-819C-408B-8387-BC4186CA956D

P932

Q30586812-D5E3FE72-7EEC-41D5-B2A4-0D140D5A78C3

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Combined effect of tumor necro ...... ation in breast cancer therapy

@en

P2093

Chenevert TL

http://www.w3.org/2001/XMLSchema#string

Chinnaiyan AM

http://www.w3.org/2001/XMLSchema#string

Hamstra DA

http://www.w3.org/2001/XMLSchema#string

Prasad U

http://www.w3.org/2001/XMLSchema#string

Rehemtulla A

http://www.w3.org/2001/XMLSchema#string

Ross BD

http://www.w3.org/2001/XMLSchema#string

Shanaiah M

http://www.w3.org/2001/XMLSchema#string

Shankar S

http://www.w3.org/2001/XMLSchema#string

P2860

A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain

FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis

The receptor for the cytotoxic ligand TRAIL

Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

An antagonist decoy receptor and a death domain-containing receptor for TRAIL

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

A novel receptor for Apo2L/TRAIL contains a truncated death domain

TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signalling

Death receptors: signaling and modulation

P304

1754-1759

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.030545097

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P577

2000-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24457094

http://www.w3.org/2001/XMLSchema#string

P698

10677530

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

26508

http://www.w3.org/2001/XMLSchema#string